Cadrenal Therapeutics (CVKD) Research & Development (2022 - 2026)
Cadrenal Therapeutics' Research & Development was $705,151 in Q2 2026, down 34.6% from $1.08 million a year earlier.
Powered by 
Analysis
Cadrenal Therapeutics (CVKD) Research & Development (2022 - 2026) Analysis & Trends
On a trailing twelve-month basis, Cadrenal Therapeutics' Research & Development was $3.82 million through Jun 30, 2026, up 2.0% year-over-year; for FY2023, it was $4.08 million, up 938.9% from FY2022.
- In earlier years, Research & Development was $392,859 in FY2022.
- The Q2 2026 figure marks the lowest quarterly Research & Development since Q1 2024.
- The best year-over-year quarter for Research & Development over five years was Q2 2024 (growth of 420.3%); the worst was Q1 2024 (a decline of 80.6%).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 4.25 Bn |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 4.65 Bn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | 2.57 Bn |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 4.54 Bn |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | 3.89 Bn |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 2.11 Bn |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | 1.61 Bn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 3.02 Bn |
| 10 | Cadrenal Therapeutics | 557,746.58 | -12.06 Mn | - | 705,151.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 705,151.00 |
| Mar 31, 2026 | 771,508.00 |
| Dec 31, 2025 | 666,323.00 |
| Sep 30, 2025 | 688,465.00 |
| Jun 30, 2025 | 1.08 Mn |
| Mar 31, 2025 | 1.67 Mn |
| Dec 31, 2024 | 1.54 Mn |
| Sep 30, 2024 | 784,646.00 |
| Jun 30, 2024 | 1.25 Mn |
| Mar 31, 2024 | 629,025.00 |
| Dec 31, 2023 | 361,127.00 |
| Sep 30, 2023 | 243,948.00 |
| Jun 30, 2023 | 240,957.00 |
| Mar 31, 2023 | 3.24 Mn |
| Dec 31, 2022 | 116,377.00 |
| Sep 30, 2022 | 56,388.00 |
| Jun 30, 2022 | 202,235.00 |
| Mar 31, 2022 | 17,860.00 |
API Access
Cadrenal Therapeutics Research & Development API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=research-and-development&ticker=CVKD&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "research-and-development", "ticker": "CVKD", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=research-and-development&ticker=CVKD&period=max&api_key=YOUR_API_KEY");
const data = await res.json();